Guo Chengbin, Tang Yuqin, Zhang Yongqiang, Li Gen
Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Front Mol Biosci. 2021 Mar 26;8:645388. doi: 10.3389/fmolb.2021.645388. eCollection 2021.
Endometrial cancer (EC) is one of the most lethal gynecological cancers around the world. The aim of this study is to identify the potential immune microenvironment-related biomarkers associated with the prognosis for EC. RNA-seq data and clinical information of EC patients were derived from The Genome Atlas (TCGA). The immune score of each EC sample was obtained by ESTIMATE algorithm. Weighted gene co-expression network analysis (WGCNA) was used to identify the interesting module and potential key genes concerning the immune score. The expression patterns of the key genes were then verified the GEPIA database. Finally, CIBERSORT was applied to evaluate the relative abundances of 22 immune cell types in EC. Immune scores were significantly associated with tumor grade and histology of EC, and high immune scores may exert a protective influence on the survival outcome for EC. WGCNA indicated that the black module was significantly correlated with the immune score. Function analysis revealed it mainly involved in those terms related to immune regulation and inflammatory response. Moreover, 11 key genes (APOL3, C10orf54, CLEC2B, GIMAP1, GIMAP4, GIMAP6, GIMAP7, GIMAP8, GYPC, IFFO1, TAGAP) were identified from the black module, validated by the GEPIA database, and revealed strong correlations with infiltration levels of multiple immune cell types, as was the prognosis of EC. In this study, 11 key genes showed abnormal expressions and strong correlations with immune infiltration in EC, most of which were significantly associated with the prognosis of EC. These findings made them promising therapeutic targets for the treatment of EC.
子宫内膜癌(EC)是全球最致命的妇科癌症之一。本研究的目的是确定与EC预后相关的潜在免疫微环境相关生物标志物。EC患者的RNA测序数据和临床信息来自于基因组图谱(TCGA)。通过ESTIMATE算法获得每个EC样本的免疫评分。使用加权基因共表达网络分析(WGCNA)来识别与免疫评分相关的有趣模块和潜在关键基因。然后在GEPIA数据库中验证关键基因的表达模式。最后,应用CIBERSORT评估EC中22种免疫细胞类型的相对丰度。免疫评分与EC的肿瘤分级和组织学显著相关,高免疫评分可能对EC的生存结果产生保护作用。WGCNA表明黑色模块与免疫评分显著相关。功能分析显示它主要涉及与免疫调节和炎症反应相关的术语。此外,从黑色模块中鉴定出11个关键基因(APOL3、C10orf54、CLEC2B、GIMAP1、GIMAP4、GIMAP6、GIMAP7、GIMAP8、GYPC、IFFO1、TAGAP),经GEPIA数据库验证,并显示与多种免疫细胞类型的浸润水平以及EC的预后密切相关。在本研究中,11个关键基因在EC中表现出异常表达并与免疫浸润密切相关,其中大多数与EC的预后显著相关。这些发现使其成为治疗EC有前景的治疗靶点。